Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Discover Royal Caribbean's strong Q2 2025 performance with increased earnings, higher net yields, and new growth initiatives.

CEO Jason Liberty told CNBC the cruise company is adapting to take advantage of evolving consumer preferences.

AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...

Tracking small-cap stocks, the Russell 2000 reversed course and skidded 0.4% lower. Volume was lower on the Nasdaq exchange ...